Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
Epilepsy Program Grants
Duration: April 1, 2020
to
present
General Issues: Medicare/Medicaid , Budget/Appropriations , Pharmacy , Medical/Disease Research/Clinical Labs , Insurance , Health Issues
Spending: about $160,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: Centers For Medicare and Medicaid Services (CMS), House of Representatives, U.S. Senate, Centers For Disease Control & Prevention (CDC), Health Resources & Services Administration (HRSA), Drug Enforcement Administration (DEA), Agency for Healthcare Research & Quality (AHRQ)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Johanna Gray
Intern, Sen. Barack Obama
Intern, Senator Barack Obama
Senator Barack Obama, Intern
Ellen Riker
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 22.
Original Filing: 301575011.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) Health Resources & Services Administration (HRSA)
4th Quarter, 2023
In Q4, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 22.
Original Filing: 301536935.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) Health Resources & Services Administration (HRSA)
3rd Quarter, 2023
In Q3, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 20, 2023.
Original Filing: 301514592.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Request for subspecialty designation of epilepsy specialists (epileptologists) under Medicare
ICD-10-CM proposals for epilepsy-related diagnosis codes
Medicare Part D, six protected classes of drugs
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) Health Resources & Services Administration (HRSA)
2nd Quarter, 2023
In Q2, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 19, 2023.
Original Filing: 301483395.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Request for subspecialty designation of epilepsy specialists (epileptologists) under Medicare
ICD-10-CM proposals for epilepsy-related diagnosis codes
Medicare Part D, six protected classes of drugs
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) Health Resources & Services Administration (HRSA)
1st Quarter, 2023
In Q1, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 20, 2023.
Original Filing: 301462502.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Request for subspecialty designation of epilepsy specialists (epileptologists) under Medicare
ICD-10-CM proposals for epilepsy-related diagnosis codes
Medicare Part D, six protected classes of drugs
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Submitted comments on Drug Enforcement Administration Notice of Proposed Rulemaking on the use of telemedicine to prescribe controlled substances.
Agencies Lobbied
Drug Enforcement Administration (DEA)
4th Quarter, 2022
In Q4, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438792.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
3rd Quarter, 2022
In Q3, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 19, 2022.
Original Filing: 301410494.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
2nd Quarter, 2022
In Q2, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 20, 2022.
Original Filing: 301394411.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
1st Quarter, 2022
In Q1, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 20, 2022.
Original Filing: 301371417.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
4th Quarter, 2021
In Q4, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 20, 2022.
Original Filing: 301332844.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
3rd Quarter, 2021
In Q3, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 20, 2021.
Original Filing: 301308325.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
2nd Quarter, 2021
In Q2, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 20, 2021.
Original Filing: 301287092.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
HR 3173, Improving Seniors Timely Access to Care Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
1st Quarter, 2021
In Q1, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on April 19, 2021.
Original Filing: 301258852.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Medicare Part D, six protected classes of drugs
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
4th Quarter, 2020
In Q4, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Jan. 20, 2021.
Original Filing: 301241188.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Comment letter on Medicare Physician Fee Schedule Proposed Rule for CY 2021
HR 133 Consolidated Omnibus Appropriations Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) U.S. House of Representatives U.S. Senate
3rd Quarter, 2020
In Q3, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on Oct. 20, 2020.
Original Filing: 301219285.xml
Lobbying Issues
Reimbursement for healthcare services provided by epilepsy centers
Telehealth services
Comment letter on Medicare Physician Fee Schedule Proposed Rule for CY 2021
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Letter to Agency for Healthcare Research and Quality (AHRQ)/Evidence-based Practice Center (EPC) Program on their systematic review on Management Strategies for Infantile Epilepsy.
Agencies Lobbied
Agency for Healthcare Research & Quality (AHRQ)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, ARTEMIS POLICY GROUP LLC lobbied for National Association of Epilepsy Centers , earning $10,000. The report was filed on July 20, 2020.
Original Filing: 301199703.xml
Lobbying Issues
Letter to CMS on coverage policy for ambulatory EEG.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Health Care at Home Act (H.R. 6644/S. 3741)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
ARTEMIS POLICY GROUP LLC filed a lobbying registration on May 12, 2020 to represent National Association of Epilepsy Centers, effective April 1, 2020.
Original Filing: 301182891.xml
Issue(s) they said they’d lobby about: Research and public health programs in epilepsy.
Healthcare issues related to the treatment of epilepsy.
Funding for epilepsy programs at CDC, HRSA, NIH.
Reimbursement for healthcare services provided by epilepsy centers.
Issues related to anti-epileptic drugs.
Implementation of the Affordable Care Act. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate